Lynn Feun
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma (NCT01639352) | Lynn Feun | 2012-07-01 |
Track Lynn Feun automatically
Every clearance here is in the API, with alerts when new ones post.